Horizon Scanning: Teaching Genomics and Personalized Medicine in the Digital Age
Publication: OMICS: A Journal of Integrative Biology
Volume 26, Issue Number 2
Abstract
Digital transformation is currently impacting not only health care but also education curricula for medicine and life sciences. The COVID-19 pandemic has accelerated the deployment of digital technologies such as the Internet of Things and artificial intelligence in diverse fields of biomedicine. Genomics and related fields of inquiry such as pharmacogenomics and personalized medicine have been making important progress over the past decades. However, the genomics knowledge of health care professionals and other stakeholders in society is not commensurate with the current state of progress in these scientific fields. The rise of digital health offers unprecedented opportunities both for health care professionals and the general public to expand their genomics literacy and education. This expert review offers an analysis of the bottlenecks that affect and issues that need to be addressed to catalyze genomics and personalized medicine education in the digital era. In addition, we summarize and critically discuss the various educational and awareness opportunities that presently exist to catalyze the delivery of genomics knowledge in ways closely attuned to the emerging field of digital health.
Get full access to this article
View all available purchase options and get full access to this article.
Disclaimer
Views expressed are the personal opinions of the authors only.
References
Forero DA, Wonkam A, Wang W, et al. (2016). Current needs for human and medical genomics research infrastructure in low and middle income countries. J Med Genet 53, 438–440.
Garcia M, Downs J, Russell A, and Wang W. (2018). Impact of biobanks on research outcomes in rare diseases: A systematic review. Orphanet J Rare Dis 13, 202.
Hou HF, Ding G, Zhao X, et al. (2019). Comparisons between protocols and publications of case-control studies: Analysis of potential causes of non-reproducibility and recommendations for enhancing the quality of personalization in healthcare. EPMA J 10, 101–108.
Kampourakis K, Vayena E, Mitropoulou C, et al. (2014). Key challenges for next-generation pharmacogenomics. EMBO Rep 15, 472–476.
Katsila T, and Patrinos GP. (2015). Whole genome sequencing in pharmacogenomics. Front Pharmacol 6, 61.
Mai Y, Koromila T, Sagia A, et al. (2011). A critical view of the general public's awareness and physicians' opinion of the trends and potential pitfalls of genetic testing in Greece. Per Med 8, 551–561.
Mai Y, Mitropoulou C, Papadopoulou XE, et al. (2014) Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece. Per Med 11, 15–26.
Pandi M-T, Koromina M, Tsafaridis I, et al. (2021). A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants. Hum Genomics 15, 51.
Patrinos GP, Baker DJ, Al-Mulla F, Vasiliou V, and Cooper DN. (2013) Genetic tests obtainable through pharmacies: The good, the bad, and the ugly. Hum Genomics 7, 17.
Pavlidis C, Karamitri A, Barakou A, et al. (2012). Ascertainment and critical assessment of the views of the general public and healthcare professionals on nutrigenomics in Greece. Per Med 9, 201–210.
Pavlidis C, Patrinos GP, and Katsila T. (2015). Nutrigenomics: A controversy. Appl Transl Genom 4, 50–53.
Pisanu C, Tsermpini EE, Mavroidi E, Katsila T, Patrinos GP, and Squassina A. (2014). Assessment of the pharmacogenomics educational environment in Southeast Europe. Public Health Genomics 17, 272–279.
Rahma AT, Elbarazi I, Ali BR, Patrinos GP, Ahmed LA, and Al Maskari F. (2020). Genomics and pharmacogenomics knowledge, attitude and practice of pharmacists working in United Arab Emirates: Findings from focus group discussions-A qualitative study. J Pers Med 10, 134.
Reydon TA, Kampourakis K, and Patrinos GP. (2012). Genetics, genomics and society: The responsibilities of scientists for science communication and education. Per Med 9, 633–643.
Squassina A, Manchia M, Manolopoulos VG, et al. (2010). Realities and expectations of pharmacogenomics and personalized medicine: Impact of translating genetic knowledge into clinical practice. Pharmacogenomics 11, 1149–1167.
Tsermpini EE, Stamopoulou T, Kordou Z, et al. (2019). Continuous pharmacogenomics and genomic medicine education for healthcare professionals through electronic educational courses. Per Med 16, 189–193.
Zhao FF, Chen Y, Ge S, et al. (2014). A quantitative analysis of the mass media coverage of genomics medicine in China: A call for science journalism in the developing world. OMICS 18, 222–230.
Information & Authors
Information
Published In
OMICS: A Journal of Integrative Biology
Volume 26 • Issue Number 2 • February 2022
Pages: 101 - 105
PubMed: 34648717
Copyright
Copyright 2022, Mary Ann Liebert, Inc., publishers.
History
Published online: 7 February 2022
Published in print: February 2022
Published ahead of print: 13 October 2021
Topics
Authors
Disclosure Statement
G.P.P. is full member and national representative at the European Medicines Agency, Committee for Human Medicinal Products (CHMP)-Pharmacogenomics Working Party, Amsterdam, the Netherlands. C.M. is managing director of the Golden Helix Foundation.
Funding Information
This study was partly funded by a Hellenic Foundation for Research and Innovation grant (HFRI-2182/2021; BioSTEM) to G.P.P.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.